Medical Device Regulatory Consulting Services

Cisema delivers specialized medical device consulting services for international clients looking to access the Chinese and Asia-Pacific markets. With a deep understanding of local regulations, we help medical device manufacturers navigate the full spectrum of regulatory compliance activities. Our bilingual consulting team, located across Europe and Asia, ensures timely, accurate, and fully compliant submission of all required regulatory documents.

Our services include registration, type testing, clinical research, post-market surveillance. Whether you're a digital health startup or a blue-chip in the medical device industry, Cisema offers hands-on support and strategic guidance tailored to your product type—covering devices, combination products, and more.

We go beyond medical device regulatory affairs. As one of the few consulting firms with cross-sector capabilities, we also serve related areas within the healthcare industry such as IVDs, pharmaceuticals, biopharma, cosmetics, health foods, veterinary medicines, and consumer goods. Our integrated approach allows clients to manage compliance across multiple verticals through one trusted partner.

Medical Device Consultant - Cisema
Outsourcing service

Discover our China Medical Device Consulting Services

Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive in China.

China Medical Device Registration

We guide you through every step of the China medical device registration and filing process. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process

Learn more

NMPA Legal Agent

We act as your official representative in China, handling registrations, filings, and ensuring you are fully compliant, including quality assurance and PMS requirements.

Learn more

NMPA Type Testing

We provide end-to-end support for China type testing in NMPA-accredited laboratories. Our experienced test engineers offer on-site supervision to guarantee accurate and reliable results.

Learn more

China Clinical Trials

You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research consultants will advise you, prepare the study protocol and assist setting up the clinical trial in China.

Learn more

NMPA Clinical Evaluation Report

CERs can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA-compliant CERs.

Learn more

Drug Device Combination Products

We assist with the classification, registration, and compliance of combination products in China, whether drug or device-led.

Learn more

China Medical Device Quality Compliance

We help you achieve and ensure ongoing compliance with Chinese requirements.Our experts prepare and assist you for official NMPA inspections.

Learn more

Medical Device PMS & Vigilance

The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.Our specialist PMS team means you remain fully compliant at all tims.

Learn more

Regulatory Outsourcing

Leverage our team of consultants and subject matter experts for specialized projects or long-term regulatory resource needs.

Learn more
Medical Device Consultant

Our Hong Kong Medical Device 
Consulting Services

Our Hong Kong Medical Device Consulting Services provide targeted support to help you meet regulatory requirements and launch your products with confidence.

Hong Kong Local Responsible Person

We act as your designated Local Responsible Person (LRP), fulfilling listing and PMS obligations under MDACS.

Learn more

Hong Kong Medical Device Registration

We support you through every stage of the Hong Kong Medical Device Listing process. From classification to handling regulatory requirements, we make the process as smooth as possible.

Learn more

Regulatory Outsourcing

If you are seeking specific specialist expertise or have ongoing resource-intensive needs, our team of consultants has a variety of solutions to meet your needs.

Learn more

Discover Our Other Medical Device Consulting Services Across APAC

Malaysia

Singapore

Vietnam

Taiwan

Indonesia

The Philippines

Thailand

South Korea

Useful Articles

View More

How China IVD Risk Classification Determines Your NMPA Registration Pathway

Learn how China IVD risk classification works under NMPA rules and see common compliance pitfalls to avoid.

July 13, 2026
How China IVD Risk Classification Determines Your NMPA Registration Pathway

A Guide to South Korea Medical Device Regulation for Global Manufacturers

Understand South Korea’s medical device regulations, from classification to approval and post-market compliance.

July 10, 2026
A Guide to South Korea Medical Device Regulation for Global Manufacturers

Understanding South Korea's Strategic Roadmap for Digital Medical Product Safety Management

Learn how MFDS’s Digital Medical Product Safety Management Roadmap will shape future compliance requirements for digital medical products in Korea.

July 10, 2026
Understanding South Korea's Strategic Roadmap for Digital Medical Product Safety Management
Stock photo of a Korean man in his early 30s sitting comfortably in a bright, contemporary apartment in South Korea, casually reviewing a health monitoring app on his smartphone while wearing a small continuous glucose monitor (CGM) sensor on his arm.

What Is the MFDS? Understanding South Korea’s Medical Device Authority

Learn how South Korea’s Ministry of Food and Drug Safety regulates medical devices, including classification, application review and post-market duties.

July 10, 2026
What Is the MFDS? Understanding South Korea’s Medical Device Authority

Explained: South Korea Medical Device Classification (Class I, II, III, & IV)

Learn how South Korea medical device classification works under the MFDS.

July 10, 2026
Explained: South Korea Medical Device Classification (Class I, II, III, & IV)
Stock photo of an adult South Korean patient wearing a continuous glucose monitor (CGM) on the upper arm during a routine appointment in a modern hospital outpatient clinic

China NMPA Fee Catalogue for Drugs & Medical Devices

Learn the latest China NMPA registration fees for imported and domestic drugs and medical devices.

July 10, 2026
China NMPA Fee Catalogue for Drugs & Medical Devices
Previous
Previous

Other Industries We Support

In addition to medical devices, we offer consulting services across regulated industries including IVDs, pharmaceuticals, biopharma, quasi-drugs, cosmetics, health foods, veterinary products, and other industrial and consumer goods. Our team ensures tailored regulatory compliance strategies, regardless of product category or manufacturing model.

Latest Insights

View More

China Expands MRI Registration Requirements Under New 2026 Review Guideline

Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.

July 16, 2026
China Expands MRI Registration Requirements Under New 2026 Review Guideline
Chinese male MRI technician in a clinical, sterile medical imaging room. The man has a warm, focused expression and is wearing a dark blue medical-style t-shirt

China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

China's new BCI medical device guidance establishes classification and naming principles, giving manufacturers a clearer pathway to NMPA registration.

July 14, 2026
China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration

New Hainan MPA guidance clarifies how Lecheng real-world evidence can support imported product registration, labeling updates, and post-approval activities

July 2, 2026
Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration
A clinical trial in Hainan, China, inside a clinical research consultation room at a  hospital. A Chinese doctor in a white lab coat seated across from an adult study participant discussing routine trial procedures, a second researcher reviewing data.

Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026

MDA will issue only electronic establishment licenses, affecting medical device manufacturers, importers, and distributors.

June 11, 2026
Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026
stock photograph of a patient and healthcare professional in a modern Malaysian hospital cardiology department

Indonesia Removes IDAK Renewals Under New Licensing Framework

Indonesia removes IDAK renewals, mandates SDAK and IPAK transitions, and shortens correction timelines under risk-based licensing.

June 11, 2026
Indonesia Removes IDAK Renewals Under New Licensing Framework

Malaysia MDA Publishes First Edition Guidance on Change Management for Registered Medical Devices

New MDA guidance introduces a risk-based framework for managing post-registration medical device changes, including software updates and SaMD.

June 11, 2026
Malaysia MDA Publishes First Edition Guidance on Change Management for Registered Medical Devices
stock photo of an advanced handheld vein visualization device being used by a Malaysian nurse in a modern private hospital treatment room in Malaysia
Previous
Previous

Get in Touch with Our Medical Device Consultants

Speak to our consultants to learn how our comprehensive services, regulatory guidance, and operational expertise can help you stay ahead in the complex medical device regulatory environment of China and Southeast Asia.

Request Proposal